Krystal Biotech's Vyjuvek gains European approval for rare skin disease treatment
Krystal Biotech's groundbreaking gene therapy for a rare skin condition is poised to make waves across the Atlantic, with European regulators giving their stamp of approval.
Krystal Biotech's groundbreaking gene therapy for a rare skin condition is poised to make waves across the Atlantic, with European regulators giving their stamp of approval. 
